NCT02481518View on ClinicalTrials.gov

Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Acute Kidney Injury
Interventions
DRUG

Magnesium

Pre loading fluid with Magnesium sulphate 16 milliequivalent plus potassium chloride 20 milliequivalent in Normal saline 500 ml IV drip in 4 hours before Cisplatin administration

OTHER

Control

Potassium chloride 20 milliequivalent in Normal saline 500 ml IV drip in 4 hours before Cisplatin administration

Trial Locations (1)

10400

Faculty of medicine, Ramathibodi Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT02481518 - Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity | Biotech Hunter | Biotech Hunter